Literature DB >> 12565150

Characterization of a recombinant Newcastle disease virus expressing the green fluorescent protein.

Ines Engel-Herbert1, Ortrud Werner, Jens P Teifke, Teshome Mebatsion, Thomas C Mettenleiter, Angela Römer-Oberdörfer.   

Abstract

A recombinant Newcastle disease virus (NDV) expressing the green fluorescent protein (GFP) was generated by applying reverse genetics techniques. The GFP open reading frame flanked by NDV transcription start and stop sequences was inserted between the fusion (F)- and hemagglutinin-neuraminidase genes in a full-length cDNA clone of NDV. This plasmid transcribing antigenome RNA was cotransfected with helper plasmids expressing viral nucleoprotein, phosphoprotein and large protein into cells stably expressing T7 RNA polymerase. The rescued virus was first propagated in embryonated eggs and the allantoic fluid was used to infect cells. Northern blot analysis of RNA isolated from infected cells demonstrated the proper transcription of the introduced GFP-mRNA. The appearance of GFP in live infected cells confirmed further the recovery of a recombinant NDV (rNDVGFP1) expressing the reporter gene. The expression of the heterologous gene was maintained stably for at least five passages in embryonated eggs. The replication kinetics in embryonated eggs and pathogenicity in chickens of rNDVGFP1 did not differ significantly from that of the parent virus. Using GFP autofluorescence, virus infected cells could be tracked easily in native preparations, organ explants and primary tracheal cell cultures. Taken together, these data demonstrate the use of GFP-expressing recombinant NDV for analysis of NDV dissemination and pathogenesis and indicate the potential usefulness of NDV as a vaccine vector.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565150     DOI: 10.1016/s0166-0934(02)00247-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.

Authors:  Jutta Veits; Dorothee Wiesner; Walter Fuchs; Bernd Hoffmann; Harald Granzow; Elke Starick; Egbert Mundt; Horst Schirrmeier; Teshome Mebatsion; Thomas C Mettenleiter; Angela Römer-Oberdörfer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

2.  Genetically engineered Newcastle disease virus for malignant melanoma therapy.

Authors:  D Zamarin; A Vigil; K Kelly; A García-Sastre; Y Fong
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

3.  The cytoplasmic location of chicken mx is not the determining factor for its lack of antiviral activity.

Authors:  Camilla T O Benfield; Jon W Lyall; Laurence S Tiley
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

4.  Hybrid- and complex-type N-glycans are not essential for Newcastle disease virus infection and fusion of host cells.

Authors:  Qing Sun; Lixiang Zhao; Qingqing Song; Zheng Wang; Xusheng Qiu; Wenjun Zhang; Mingjun Zhao; Guo Zhao; Wenbo Liu; Haiyan Liu; Yunsen Li; Xiufan Liu
Journal:  Glycobiology       Date:  2011-09-28       Impact factor: 4.313

5.  Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge.

Authors:  Minhua Sun; Jiawen Dong; Linlin Li; Qiuyan Lin; Junying Sun; Zhicheng Liu; Haiyan Shen; Jianfeng Zhang; Tao Ren; Chunhong Zhang
Journal:  Vet Microbiol       Date:  2018-03-28       Impact factor: 3.293

6.  Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes.

Authors:  J Fréderique de Graaf; Stefan van Nieuwkoop; Theo Bestebroer; Daphne Groeneveld; Casper H J van Eijck; Ron A M Fouchier; Bernadette G van den Hoogen
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

7.  Expression and stability of foreign epitopes introduced into 3A nonstructural protein of foot-and-mouth disease virus.

Authors:  Pinghua Li; Xingwen Bai; Yimei Cao; Chenghao Han; Zengjun Lu; Pu Sun; Hong Yin; Zaixin Liu
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.